NexturnBioscience Co. Ltd (089140) — Cash Flow Reinvestment Rate
NexturnBioscience Co. Ltd (089140) has a Cash Flow Reinvestment Rate of 1.08x as of September 2025, reinvesting ₩4.89 Billion (capex ₩286.65 Million plus investments ₩4.61 Billion) from operating cash flow of ₩4.51 Billion. Explore 089140 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NexturnBioscience Co. Ltd Cash Flow Reinvestment Rate (2007–2021)
Historical reinvestment intensity for NexturnBioscience Co. Ltd across 12 annual periods. Also explore NexturnBioscience Co. Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for NexturnBioscience Co. Ltd (2007–2021)
Year-by-year capital reinvestment analysis for NexturnBioscience Co. Ltd. For live market cap and broader valuation context, see 089140 market cap.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 19.97x | ₩73.16 Billion | ₩3.66 Billion | ₩467.60 Million | ▲ +93.3% |
| 2020 | 10.33x | ₩2.44 Billion | ₩235.94 Million | ₩1.21 Billion | ▼ -19.5% |
| 2019 | 12.84x | ₩35.12 Billion | ₩2.74 Billion | ₩18.38 Billion | ▲ +1943.5% |
| 2018 | 0.63x | ₩6.05 Billion | ₩9.63 Billion | ₩199.42 Million | ▼ -78.5% |
| 2017 | 2.92x | ₩14.85 Billion | ₩5.08 Billion | ₩870.45 Million | ▲ +30.0% |
| 2016 | 2.25x | ₩40.18 Billion | ₩17.88 Billion | ₩893.46 Million | ▲ +53.2% |
| 2015 | 1.47x | ₩2.81 Billion | ₩1.92 Billion | ₩906.54 Million | ▲ +8439.7% |
| 2014 | 0.02x | ₩111.27 Million | ₩6.48 Billion | ₩8.97 Million | ▼ -99.8% |
| 2010 | 10.33x | ₩2.44 Billion | ₩235.94 Million | ₩1.21 Billion | ▲ +3793.4% |
| 2009 | 0.27x | ₩264.83 Million | ₩998.03 Million | ₩68.11 Million | ▼ -26.3% |
| 2008 | 0.36x | ₩340.32 Million | ₩945.34 Million | ₩197.16 Million | ▼ -86.9% |
| 2007 | 2.75x | ₩6.22 Billion | ₩2.26 Billion | ₩3.97 Billion | — |